Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Organ Preservation Companies

ID: MRFR/HC/4615-CR
169 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Organ preservation involves the process of maintaining organs outside the body for transplantation. Various companies focus on developing and providing technologies and solutions for organ preservation, ensuring the organs remain viable and functional before transplantation.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Organ Preservation Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)6.70%
2025 Market SizeUSD 358.6 Million
2035 Market SizeUSD 685.8 Million
Key Players
XVIVO Perfusion AB
TransMedics Group
Organ Recovery Systems
Bridge to Life Ltd.
OrganOx Ltd.
Paragonix Technologies
Opportunities
  • Viability Assessment as a Billable Service
  • Emerging-Market Transplant Infrastructure
  • Organ Repair and Reconditioning

Top Industry Leaders in the Organ Preservation Market

Organ Preservation Key Companies

Latest Organ Preservation Companies Update

  • Oct 2023: For a maximum of $5.8 billion, Bristol-Myers Squibb said that it will buy cancer manufacturer Mirati Therapeutics. The company intends to partially offset the revenue loss anticipated from patent expirations in the coming years by broadening its oncology business and acquiring new medications. Bristol will acquire Mirati's portfolio of medications, which includes the December-approved lung cancer treatment Krazati, that target the genetic causes of tumors. The business was also drawn to a second molecule, MRTX1719, which may be employed in certain lung cancer cases. The business announced its plan to purchase Mirati for cash for $58 per share, or roughly $4.8 billion.
Get In-Depth Insights on Key Organ Preservation Companies
  • Jul 2023: The heart-lung machine priming research by organ transplant medtech startup XVIVO Perfusion AB has ended, and the business has announced that it will now assess the product's commercial potential. In 2017, the solution known as PrimECC showed encouraging safety outcomes. The new trial was started in 2020, and the Swedish company hoped it would increase the size of the clinical dataset for PrimECC. However, XVIVO identified general difficulties in locating recruiting locations, non-fulfillment of criteria, and COVID-19-related patient enrollment issues as explanations for the trial's failures. The 2016 CE-marked solution keeps air bubbles from getting into the bloodstream by being introduced to heart-lung machines used in cardiopulmonary bypass surgeries. Right now, saline is applied.

List of Organ Preservation Key companies in the market

  • Trans Medics Group Inc.
  • Bristol Myers Squibb
  • Artivion Inc.
  • Xvivo Perfusion AB
  • Accord Healthcare Limited
  • BioLife Solutions Inc.
  • Shanghai Genext Medical Technology Co.Ltd.